U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C13H16N4
Molecular Weight 228.2929
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of MIFENTIDINE

SMILES

CC(C)N\C=N\C1=CC=C(C=C1)C2=CN=CN2

InChI

InChIKey=GOZUADYOHPCXLE-UHFFFAOYSA-N
InChI=1S/C13H16N4/c1-10(2)15-9-16-12-5-3-11(4-6-12)13-7-14-8-17-13/h3-10H,1-2H3,(H,14,17)(H,15,16)

HIDE SMILES / InChI

Molecular Formula C13H16N4
Molecular Weight 228.2929
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Mifentidine, a histamine H2 receptor antagonist, was studied to treat the duodenal ulcer. This drug was in phase II clinical trials when apparently further researches had been discontinued.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P25021
Gene ID: 3274.0
Gene Symbol: HRH2
Target Organism: Homo sapiens (Human)
PubMed

PubMed

TitleDatePubMed
In vitro studies on the metabolic fate of mifentidine, a novel histamine H2-receptor antagonist.
1997-04-01
In vivo-in vitro correlations with a commercial dissolution simulator. Studies on the H2 receptor antagonist mifentidine.
1996-10
The effect of the new H2-receptor antagonist mifentidine on gastric secretion, gastric emptying and experimental gastric and duodenal ulcers in the rat: comparison with cimetidine and ranitidine.
1986
Mifentidine: evaluation of antiandrogen effects and kidney function studies.
1985

Sample Use Guides

mifentidine 20 mg at night
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:57:33 GMT 2025
Edited
by admin
on Mon Mar 31 17:57:33 GMT 2025
Record UNII
2F70KF5S0K
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MIFENTIDINE
INN   MART.  
INN  
Official Name English
MIFENTIDINE [MART.]
Preferred Name English
mifentidine [INN]
Common Name English
N-(P-IMIDAZOL-4-YLPHENYL)-N'-ISOPROPYLFORMAMIDINE
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29578
Created by admin on Mon Mar 31 17:57:33 GMT 2025 , Edited by admin on Mon Mar 31 17:57:33 GMT 2025
Code System Code Type Description
CAS
83184-43-4
Created by admin on Mon Mar 31 17:57:33 GMT 2025 , Edited by admin on Mon Mar 31 17:57:33 GMT 2025
PRIMARY
NCI_THESAURUS
C66149
Created by admin on Mon Mar 31 17:57:33 GMT 2025 , Edited by admin on Mon Mar 31 17:57:33 GMT 2025
PRIMARY
SMS_ID
100000080609
Created by admin on Mon Mar 31 17:57:33 GMT 2025 , Edited by admin on Mon Mar 31 17:57:33 GMT 2025
PRIMARY
INN
5370
Created by admin on Mon Mar 31 17:57:33 GMT 2025 , Edited by admin on Mon Mar 31 17:57:33 GMT 2025
PRIMARY
MESH
C039796
Created by admin on Mon Mar 31 17:57:33 GMT 2025 , Edited by admin on Mon Mar 31 17:57:33 GMT 2025
PRIMARY
FDA UNII
2F70KF5S0K
Created by admin on Mon Mar 31 17:57:33 GMT 2025 , Edited by admin on Mon Mar 31 17:57:33 GMT 2025
PRIMARY
EVMPD
SUB08955MIG
Created by admin on Mon Mar 31 17:57:33 GMT 2025 , Edited by admin on Mon Mar 31 17:57:33 GMT 2025
PRIMARY
PUBCHEM
71263
Created by admin on Mon Mar 31 17:57:33 GMT 2025 , Edited by admin on Mon Mar 31 17:57:33 GMT 2025
PRIMARY
EPA CompTox
DTXSID00232208
Created by admin on Mon Mar 31 17:57:33 GMT 2025 , Edited by admin on Mon Mar 31 17:57:33 GMT 2025
PRIMARY
ChEMBL
CHEMBL308005
Created by admin on Mon Mar 31 17:57:33 GMT 2025 , Edited by admin on Mon Mar 31 17:57:33 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY